Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and internationally. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunot...
Q2 2026
Aug 11, 2026
Q1 2026
May 12, 2026
FY 2025
Mar 16, 2026
Q4 2025
Q3 2025
Nov 12, 2025